The multipotent mesenchymal stem cells (MMSCs) play an important role in the regeneration processes. It is known that the MMSCs were first obtained by Fridenstein as fraction of the bone marrow cells which were characterized by adhesion to plastic surface and colony-formation during their ex vivo culture [1, 2] . It is noteworthy that the MMSCs were discovered from other tissues like subcutaneous adipose tissue, muscles, umbilical blood and others.
have greater expression of CD44, CD166 markers, whereas CD105 is less expressed. Separate antigen determinants characteristic of normal human MMSCs, namely CD73, CD90 and Stro-1 are not detected. Several investigators demonstrated their greatly limited potential to separate kinds of differentiation. After transformation one observes a significant reduction of differentiation in the adipogenic and chondrogenic direction. Instead, the transformed MMSCs have greater potential to osteogenic differentiation under definite conditions. The main property of the transformed stem cells is their tumorogenicity. For instance, G. Rоsland and colleagues assessed the tumorogenic activity of spontaneously transformed human MMSCs in vivo by injecting these cells to immunedeficient NOD/SCID mice [27] . Earlier these investigators had conducted eGFP gene transduction for further monitoring of tumor growing in the lungs. On day 9 they registered first foci of tumor growth in the lungs.
Respectively, the animals injected normal MMSCs did not manifest tumor process. The histological analysis of tumors showed that lung metastases were epithelioid by their morphological signs but they had the markers of both mesenchymal and epithelial direction of differentiation. Analogous investigation was carried out by the Rubio group although they used the spontaneously transformed MMSCs of the subcutaneous adipose tissue obtained after long-term culturing. After injection of the given cells to immune-deficient mice the multiple foci of tumor growth appeared in the lung, liver, brain, kidneys and heart [26] . The abovementioned investigations have proved the fact that transformed MMSCs can initiate sarcomogenesis and thus play role of tumor-initiating cells.
THEORY OF CANCER STEM CELLS
In view of the above-said it is worthwhile to consider the theory of cancer stem or tumor-initiating cells. First of all, the terms "tumor stem cells" and "tumor-initiating cells" are synonymous. At the same time the term "tumor stem cells" is more known in the literature although it does not adequately reflect tissue genesis of malignancies and it is rather used by tradition.
According to the theory of cancer stem cells or tumor-initiating cells, tumors are formed from stem cells (stem cells from adult organism included) or their progenitors with a high proliferative potential resultant from appearance in the latter of changes in the genetic programs regulating normal tissue regeneration. Besides, changes occur in the micro environment of the transformed stem cell. As a result of such initiation of tumors, there takes place formation of a peculiar hierarchic structure which is resembles regeneration processes of the normal tissues. It is the hierarchy of cells in the normal tissue and malignant tumors with the stem cells at the top forming the pool of progenitors with lesser proliferative and differential potential. The progenitors, in turn, form terminal link of this hierarchic structure -the differentiated cells. The mentioning here should be made of the clonal evolution concept that has dominated in oncology for a long time and determined similar potention for tumorogenesis of all tumor cells. The concept of tumor-initiating cells states that only transformed stem cells can generate tumor, following from their properties for renewal and greater proliferative potential [28] [29] [30] [31] .
Notably, many sarcomas of various localization are characterized by their resistance to cytotoxic agents thus showing certain analogy with normal stem cells. The greatest level of resistance is characteristic of low-differentiated sarcomas. It is known that MMSCs hyperexpress proteins which are able to eliminate cytotoxic substances [32, 33, 34] . For instance, some investigators provide evidence for P-glycoprotein expression in the latter and reduced level of its expression during cells differentiation [35] . Obviously, the above-mentioned properties are not lost after MMSCs transformation and condition, in turn, the presence of recurrences following chemotherapy. In addition, there is certain analogy between normal stem cell heterogeneity and tumor-initiating cells by their proliferative potential and morphologic properties. The stem cells are characterized by asymmetric division following which there appear de novo stem cells and more differentiated progenitors with a considerably lower proliferative potential and other morphologic characteristics. Analogous processes take place in the tumor but with aberrant differentiation. In accord with the above-said, many investigators have reported the existence in the heterogenic tumor population of a minor/n insignificant fraction of cells capable to generate tumor-initiating cells. This conception has been confirmed many times experimentally. Thus, after transplantation of different cell populations derived from various tumor cells in animals it was seen that only one of them was tumorogenic [28] [29] [30] [31] .
MODELS OF SARCOMOGENESIS CONDITIONED BY TRANSFORMED MMSCs
The two main models of sarcomogenesis induced by transformed MMSCs are being analyzed within the framework of the conception about the existence of tumor-initiating cells. The first model is based on the possibility of MMSCs transformation at different levels of their differentiation. Thus, the given model explains the existence of sarcomas of different level of differentiation. According this model, low-differentiated sarcomas are formed from MMSCs and their early progenitors. Respectively, highly-differentiated sarcomas are formed as a result of oncogenic mutations in terminally differentiated MMSCs. According to this model, phenotypic characteristics, histological structure of the sarcoma are determined depending on the direction of MMSCs differentiation, stage of MMSCs differentiation on which it was initiated [36] . For instance, using this model it is possible to explain different levels of osteosarcoma differentiation [36, 37] . Also, this model has been confirmed by the profile of expression of the genes committed to one or another direction of MMSCs differentiation. For instance, chondrosarcoma cells manifest significant phenotypic affinity to mature chondrocytes. At the same time, the profile of genetic expression of less differentiated form of sarcoma manifests greater analogy with the profile of genetic expression of pre-chondrogenic stage of MMSCs differentiation [36, 38] .
As a result of stable constitutive proliferation of MMSCs, a pool of malignant cells with various morphological properties is formed, in which in turn additional mutations occur. Indeed, this non-uniformity is explained by genetic changes in the latter. Further there appears a probability of formation of immortal clone with partial or complete loss of the ability for differentiation that explains formation of sarcomas with various stage of differentiation [36] .
There exists another model of sarcomogenesis conditioned by MMSCs transformation. According to this model, due to mutations taking place in MMSCs the latter gain the capacity for constitutional active symmetric and asymmetric proliferation. As a result of constitutional proliferation of MMSCs there forms a pool of the tumor cells with various morphological properties in which in turn additional mutations occur. Such irregularities are explained by genetic changes in the latter. Further there appears the possibility of formation of immortalized clone with partial or complete loss of the ability for differentiation and thereby the formation of sarcomas with varying degree of differentiation is explained [36] .
POSSIBLE GENETIC MMSCs CHANGES INITIATING SARCOMOGENESIS
In the context of the above-given conceptions about sarcomogenesis one of its triggers can be the hyper activating mutation of TERT gene coding telomerase. As a result, MMSCs can acquire immortal phenotype with an unlimited proliferating potential. It is known that high endogenous telomerase activity is observed in 70-90 % of malignant cell lines whereas in normal MMSCs the activity one observes more significant activity of this factor. Owing to high telomerase activity, MMSCs are cable to pass the period of crisis during culturing. Unlimited proliferating activity can be conditioned by hyperexpression of c-myc oncogene. It is known, that 30 % of MMSCs, which pass aging stage, are characterized with an increased c-myc oncogene expression. Further increase of this gene expression is seen in the transformed MMSCs. In its turn, c-myc as diagnostic marker of various sarcomas. It is known, that Ewing sarcoma possesses EWS-FLI-1 chimera-gene expression. The given chimera-gene is considered as one of the diagnostic markers of the Ewing sarcoma. However, in transduction of human MMSCs by EWS-FLI-1 gene one does not observe tumorogenesis in the immunedeficient animals following injection of the given cells. At the same time transduced MMSCs manifested great analogy in the pattern of genetic expression with the pattern of genetic expression of the Ewing sarcoma cells. Obviously, in order for the transduced MMSCs to gain the capacity for tumorogenesis, additional genetic changes are necessary. Analogous investigations were carried out with the use of transduction of chimera FUS-CHOP gene, the presence of which is characteristic for human fibrosarcoma cells. Although injection of transduced MMSCs of the given chimeric gene did not promote tumor formation [40] . The investigators assume that additional combination of mutations is necessary for FUS-CHOP-transduced MMSCs to gain their tumorogenic potential. There is an assumption that such mutation can be inactivating p53 gene mutation or its deletion. The above-said investigations indicate that expression of such chimeric genes in MMSCs is obligatory but not sufficient condition in tumorogenesis. The role of given genetic disturbances in sarcomogenesis needs further investigation [41] .
oncogene hyperexpression can be conditioned by inactivating mutations in the genes of inhibitors of cycline-dependent kinases of INK4 family/ group (15INK4B, р16INK4A, р18INK4C and р19INK4D proteins) which, as a rule, can bind with cycline-D-dependent Cdk4 and Cdk6 kinases [39, 27] . It is known, that in the absence of inhibiting action of cyclinedependent kinases the latter can phosphorilate Rb factor. In the case of Rb factor phosphorilation there occurs its dissociation with transcriptional E2F1 factor and the latter gains the capacity to bind with c-myc oncogene promoter, thereby stimulating cell proliferation. An unlimited proliferating activity creates predisposition for further accumulation of oncogenic mutations. Under conditions of an increased proliferation the reparation processes are worsened. Therefore, the level of genetic instability can be increased [39] . With increasing genetic instability level the proliferation and differentiation processes are disturbed and lead to the appearance of tumorogenic clone.
As a result of genetic instability of the transformed MMSCs there can be various chromosome aberrations which condition deregulation of the processes of their normal differentiation and proliferation. The so-called fusion genes (genes-chimeras), being formed as a result of chromosomal translocations, play great role in the sarcomogenesis processes. The presence of certain chimera genes serves/ is used 
